[Therapy related changes in leukemias].
D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001151:Arsenic / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003480:Cushing Syndrome / Q000209:etiology; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010026:Osteosclerosis / Q000139:chemically induced; D010437:Peptic Ulcer / Q000209:etiology; D011241:Prednisone / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects; D018805:Sepsis / Q000209:etiology; D013923:Thromboembolism / Q000209:etiology; D065227:Transfusion Reaction
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D001151:Arsenic; D011241:Prednisone
Therapiebedingte Veränderungen bei Leukämien.